Mirion Technologies/$MIR
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Mirion Technologies
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
- Ticker
- $MIR
- Sector
- Digital Hardware
- Primary listing
- NYSE
- Employees
- 3,281
- Headquarters
- Atlanta, United States
- Website
- www.mirion.com
MIR Metrics
BasicAdvanced
$4B
156.29
$0.11
1.10
-
Price and volume
Market cap
$4B
Beta
1.1
52-week high
$30.28
52-week low
$14.04
Average daily volume
4.4M
Financial strength
Current ratio
3.018
Quick ratio
2.295
Long term debt to equity
0.673
Total debt to equity
0.677
Interest coverage (TTM)
2.33%
Profitability
EBITDA (TTM)
233
Gross margin (TTM)
48.12%
Net profit margin (TTM)
2.69%
Operating margin (TTM)
7.37%
Effective tax rate (TTM)
24.44%
Revenue per employee (TTM)
$330,000
Management effectiveness
Return on assets (TTM)
1.42%
Return on equity (TTM)
1.63%
Valuation
Price to earnings (TTM)
156.292
Price to revenue (TTM)
3.786
Price to book
2.25
Price to tangible book (TTM)
-6.81
Price to free cash flow (TTM)
24.332
Free cash flow yield (TTM)
4.11%
Free cash flow per share (TTM)
0.688
Growth
Revenue change (TTM)
19.65%
Earnings per share change (TTM)
5.58%
3-year revenue growth (CAGR)
11.05%
3-year earnings per share growth (CAGR)
-55.62%
What the Analysts think about MIR
Analyst ratings (Buy, Hold, Sell) for Mirion Technologies stock.
Analyst projections of the future price of Mirion Technologies stock.
Bulls say / Bears say
Core demand is strengthening: Q2 orders rose 10% excluding acquisitions, while nuclear-power orders increased 50%, supporting a growing backlog and future revenue conversion. (Mirion Technologies)
Profitability and cash generation improved: Q2 adjusted EBITDA rose 27.5% to $65.3 million, with margin expansion across both segments and $49 million of adjusted free cash flow. (Mirion Technologies)
Mirion’s installed-base exposure offers recurring opportunities beyond reactor construction; Jefferies highlighted demand from plant life extensions, uprates and modernisation. (Investing.com)
Headline growth overstates underlying momentum: Q2 revenue rose 19.7%, but organic growth was only about 1%, with acquisitions contributing much of the increase. (Mirion Technologies, Investing.com)
Medical was soft: segment organic revenue fell 0.9% in Q2, as nuclear-medicine hardware demand was delayed and dosimetry growth expectations were lowered. (Mirion Technologies)
Reported earnings remain thin and share dilution is rising: GAAP net income slipped to $8.1 million from $8.5 million, while diluted weighted-average shares rose to 275 million from 243 million year on year. (U.S. Securities and Exchange Commission)
Data summarised monthly by Lightyear AI. Last updated on 27 Oct 2026.
MIR Financial Performance
Revenues and expenses
MIR Earnings Performance
Company profitability
Upcoming events
No upcoming events
MIR News
AllArticlesVideos
What Mirion Technologies (MIR) Said on Its Q3 Earnings Call
MarketBeat17 hours ago
Mirion Extends Support of IAEA Mission to Advance Cancer Care Globally through Rays of Hope Donation
Business Wire1 week ago
Mirion Announces Earnings Release and Conference Call Date for Third Quarter 2026
Business Wire2 weeks ago
Funds containing MIR
AllUSDEURGBP
Fund name | Fund size | $MIR weighting |
|---|---|---|
Invesco Defence Innovation$IDFN | $161M | 1.17% |
Invesco Defence Innovation£DFNX | $161M | 1.17% |
iShares Digital Security€L0CK | $1.9B | 0.66% |
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.22% |
iShares S&P Small Cap 600£ISP6 | $3.2B | 0.22% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.